TUBERTEST, solution for injection, dérivé protéinique purifié of tuberculine 10 doses
Active ingredients: TUBERCULINE PURIFIÉE
Commercialized according to BDPM
Solution for injection10 dosesintradermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TUBERTEST, solution injectable, dérivé protéinique purifié de tuberculine
- Pharmaceutical form
- solution injectable
- Route of administration
- intradermique
- Presentation description
- 1 flacon(s) en verre de 10 dose(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66785434CIP73539550CIP133400935395504Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TUBERCULINE PURIFIÉEsolution | 5 UI · une dose de 0,1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.